Nanaomycin A is the first selective DNMT3B inhibitor with an IC50 of 500 nM. Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A inhibits in vitro growth of the human malaria parasite Plasmodium falciparum with an IC80 value of 33.1 nM.
体外研究
Nanaomycin A (10-10000 nM; 72 hours) has a distinct cytotoxic effect in all three cell lines.
Nanaomycin A (0.5, 5 μM; 72 hours) reveals induction of RASSF1A protein expression in A549 cells.
Nanaomycin A (5 μM; 72 hours) has an 18-fold relative induction.
Nanaomycin A not affects the enzymatic activity of DNMT1.
Cell Cytotoxicity Assay
Cell Line:
HCT116 (colon), A549 (lung), and HL60 (bone marrow) human tumor cell lines
Concentration:
10, 100, 1000, 10000 nM
Incubation Time:
72 hours
Result:
Had a distinct cytotoxic effect in all three cell lines.
Western Blot Analysis
Cell Line:
A549 cells
Concentration:
0.5, 5 μM
Incubation Time:
72 hours
Result:
Revealed induction of RASSF1A protein expression.
RT-PCR
Cell Line:
A549 cells
Concentration:
5 μM
Incubation Time:
72 hours
Result:
Had an 18-fold relative induction.
分子式
C16H14O6
分子量
302.28
CAS号
52934-83-5
运输条件
Room temperature in continental US; may vary elsewhere.